Opening book details…
About this Economics, Econometrics and Finance article
The Cost-Effectiveness of Bendamustine-Rituximab (Ben-R) Versus R-Chop for the First Line Treatment of Patients with Indolent Non-Hodgkin’s Lymphoma (Inhl) in Colombia by Wehler, EA; Kowal, S; Ariza, JG; Zambrano, C; de Anda, JA; Anaya, P; Munakata, J; Gonzalez, L is a Economics, Econometrics and Finance article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Economics, Econometrics and Finance.
- Author
- Wehler, EA; Kowal, S; Ariza, JG; Zambrano, C; de Anda, JA; Anaya, P; Munakata, J; Gonzalez, L
- Publisher
- John Wiley and Sons; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 1098-3015)
- Published
- 2015
- Field
- Economics, Econometrics and Finance (Social Sciences)